PosiFunda · Fundamentals

Iambic Therapeutics, Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (4)

Iambic Therapeutics, Inc. made a loss over the last year.

Compared with Healthcare companies in United States.

P/E ratio

Loss

Iambic Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-1.45

Iambic Therapeutics, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$676 M

The total market value of all of Iambic Therapeutics, Inc.'s shares at today's price (share price × number of shares), larger than 60% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Dividend yield

None

Iambic Therapeutics, Inc. does not currently pay a dividend.

Questions

Does Iambic Therapeutics, Inc. pay a dividend?

No. Iambic Therapeutics, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.